Alnylam Pharmaceuticals
ALNY
#638
Rank
NZ$54.22 B
Marketcap
$418.87
Share price
-0.51%
Change (1 day)
73.99%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company